Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

2011433 citationsJournal Articlegold Open Access

Authors

Jorja D Warren

Wei Xiong · ARUP Laboratories (United States)

Ashley M. Bunker · ARUP Laboratories (United States)

Cecily P. Vaughn · ARUP Laboratories (United States)

Larissa V. Furtado · University of Utah

William L. Roberts · University of Utah

John C. Fang · University of Utah

Abstract

A sensitive blood-based CRC screening test using the SEPT9 biomarker specifically detects a majority of CRCs of all stages and colorectal locations. The test could be offered to individuals of average risk for CRC who are unwilling or unable to undergo colonscopy.

Topics & Keywords

Colorectal Cancer Screening and Detection Genetic factors in colorectal cancer Gastric Cancer Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMC Medicine

Volume 9, Issue 1, pp. 133-133

DOI: 10.1186/1741-7015-9-133

Field-Weighted Citation Impact: 11.12